Angioplasty overused among millions of patients, evidence shows
Every day, thousands of people enter hospitals for angioplasties—a procedure that will cost about $12,000, take a week of recuperation, and require a year or more of drug therapy. And, in many cases, it's probably unnecessary. Angioplasties have grown into a $10 billion industry in the United States, and there is no dispute that they can be a lifesaver for patients in the throes of a heart attack. But angioplasties aren't risk-free, and evidence is mounting that the procedure is overused among the millions of patients who have the kind of stable heart disease that doesn't foretell a heart attack. New studies indicate that cardiologists often don't evaluate these patients adequately before doing angioplasties, and patients often have inflated ideas about how important an angioplasty is to their survival.
- CMS Reveals Central Line Infection Rates, Finally
- Keeping Readmission Rates Low with Treatment Guidelines
- 5010 Logjam Means No Pay for Physicians
- Medicare Physician Payment Rule Factors in GPCI
- Leading Change is Tough from the Back of a Limo
- Feds Release Final Rules on Health Plan Language
- Getting to the Heart of Cardiology Alignment
- Engineering a High-Performance Emergency Department
- UnitedHealth will tie doctors' payments to quality of care
- What to do with an empty hospital?

